Risk Prediction Models for Kidney Cancer: A Systematic Review

被引:39
作者
Harrison, Hannah [1 ]
Thompson, Rachel E. [2 ]
Lin, Zhiyuan [2 ]
Rossi, Sabrina H. [3 ]
Stewart, Grant D. [3 ]
Griffin, Simon J. [1 ]
Usher-Smith, Juliet A. [1 ]
机构
[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England
[2] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge, England
[3] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge, England
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Kidney cancer; Early detection; Screening; Systematic review; RENAL-CELL CARCINOMA; APPLICABILITY; BIOMARKERS; SURVIVAL; PROBAST; BIAS; TOOL; AGE;
D O I
10.1016/j.euf.2020.06.024
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context: Early detection of kidney cancer improves survival; however, low prevalence means that population-wide screening may be inefficient. Stratification of the population into risk categories could allow for the introduction of a screening programme tailored to individuals. Objective: This review will identify and compare published models that predict the risk of developing kidney cancer in the general population. Evidence acquisition: A search identified primary research reporting or validating models predicting the risk of kidney cancer in Medline and EMBASE. After screening identified studies for inclusion, we extracted data onto a standardised form. The risk models were classified using the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) guidelines and evaluated using the PROBAST assessment tool. Evidence synthesis: The search identified 15 281 articles. Sixty-two satisfied the inclusion criteria; performance measures were provided for 11 models. Some models predicted the risk of prevalent undiagnosed disease and others future incident disease. Six of the models had been validated, two using external populations. The most commonly included risk factors were age, smoking status, and body mass index. Most of the models had acceptable-to-good discrimination (area under the receiver-operating curve >0.7) in development and validation. Many models also had high specificity; however, several had low sensitivity. The highest performance was seen for the models using only biomarkers to detect kidney cancer; however, these were developed and validated in small case-control studies. Conclusions: We identified a small number of risk models that could be used to stratify the population according to the risk of kidney cancer. Most exhibit reasonable discrimination, but a few have been validated externally in population-based studies. Patient summary: In this review, we looked at mathematical models predicting the likelihood of an individual developing kidney cancer. We found several suitable models, using a range of risk factors (such as age and smoking) to predict the risk for individuals. Most of the models identified require further testing in the general population to confirm their usefulness. (c) 2020 European Association of Urology. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:1380 / 1390
页数:11
相关论文
共 38 条
  • [1] ASAL NR, 1988, CANCER DETECT PREV, V13, P263
  • [2] Diabetes mellitus and incidence and mortality of kidney cancer: A meta-analysis
    Bao, Cuiping
    Yang, Xilin
    Xu, Weili
    Luo, Hongbin
    Xu, Zhongliang
    Su, Cheng
    Qi, Xiuying
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (04) : 357 - 364
  • [3] Cancer Research UK, BLADD CANC STAT
  • [4] Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index
    Colditz, GA
    Atwood, KA
    Emmons, K
    Monson, RR
    Willett, WC
    Trichopoulos, D
    Hunter, DJ
    [J]. CANCER CAUSES & CONTROL, 2000, 11 (06) : 477 - 488
  • [5] Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1038/bjc.2014.639, 10.7326/M14-0698, 10.1002/bjs.9736, 10.1136/bmj.g7594, 10.1016/j.eururo.2014.11.025]
  • [6] Twenty-year review of abdominal aortic aneurysm screening in men in the county of Gloucestershire, United Kingdom
    Darwood, Rosie
    Earnshaw, Jonothan J.
    Turton, Glenda
    Shaw, Elaine
    Whyman, Mark
    Poskitt, Keith
    Rodd, Caroline
    Heather, Brian
    [J]. JOURNAL OF VASCULAR SURGERY, 2012, 56 (01) : 8 - 14
  • [7] Implementation of the National Health Service Abdominal Aortic Aneurysm Screening Program in England
    Davis, Meryl
    Harris, Mike
    Earnshaw, Jonothan J.
    [J]. JOURNAL OF VASCULAR SURGERY, 2013, 57 (05) : 1440 - 1445
  • [8] Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
    Ferlay, J.
    Colombet, M.
    Soerjomataram, I.
    Mathers, C.
    Parkin, D. M.
    Pineros, M.
    Znaor, A.
    Bray, F.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) : 1941 - 1953
  • [9] Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
    Frantzi, Maria
    Metzger, Jochen
    Banks, Rosamonde E.
    Husi, Holger
    Klein, Julie
    Dakna, Mohammed
    Mullen, William
    Cartledge, Jonathan J.
    Schanstra, Joost P.
    Brand, Korbinian
    Kuczyk, Markus A.
    Mischak, Harald
    Vlahou, Antonia
    Theodorescu, Dan
    Merseburger, Axel S.
    [J]. JOURNAL OF PROTEOMICS, 2014, 98 : 44 - 58
  • [10] Increasing kidney cancer incidence and survival in Estonia: role of age and stage
    Innos, Kaire
    Sepp, Teesi
    Baburin, Aleksei
    Kotsar, Andres
    Lang, Katrin
    Padrik, Peeter
    Aareleid, Tiiu
    [J]. ACTA ONCOLOGICA, 2019, 58 (01) : 21 - 28